MPO and colitis: In mild colitis mice groups, after 20 mg/kg CK and 100 mg/kg BBR treatment, MPO activity in the colon was reduced by 401±41.29 mU/g (p<0.01) and 235±76.37 mU/g (p<0.05) (Fig. 2A) compared to the model group.